Cargando…

Erratum to: Iron metabolism and iron supplementation in cancer patients

Detalles Bibliográficos
Autores principales:	Ludwig, Heinz, Evstatiev, Rayko, Kornek, Gabriela, Aapro, Matti, Bauernhofer, Thomas, Buxhofer-Ausch, Veronika, Fridrik, Michael, Geissler, Dietmar, Geissler, Klaus, Gisslinger, Heinz, Koller, Elisabeth, Kopetzky, Gerhard, Lang, Alois, Rumpold, Holger, Steurer, Michael, Kamali, Houman, Link, Hartmut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713978/ https://www.ncbi.nlm.nih.gov/pubmed/26613899 http://dx.doi.org/10.1007/s00508-015-0893-5

Ejemplares similares

Iron metabolism and iron supplementation in cancer patients
por: Ludwig, Heinz, et al.
Publicado: (2015)

Ruxolitinib therapy for myelofibrosis in Austria: Consensus on therapy management
por: Krauth, Maria-Theresa, et al.
Publicado: (2018)

Effect of Iron Therapy on Platelet Counts in Patients with Inflammatory Bowel Disease-Associated Anemia
por: Kulnigg-Dabsch, Stefanie, et al.
Publicado: (2012)

Organic Anion Transporting Polypeptide 5A1 (OATP5A1) in Small Cell Lung Cancer (SCLC) Cells: Possible Involvement in Chemoresistance to Satraplatin
por: Olszewski-Hamilton, U., et al.
Publicado: (2011)

Iron, Meat and Health
por: Geissler, Catherine, et al.
Publicado: (2011)

Intravenous iron is non-inferior to oral iron regarding cell growth and iron metabolism in colorectal cancer associated with iron-deficiency anaemia
por: Al-Hassi, Hafid O., et al.
Publicado: (2021)

Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia
por: Buxhofer‐Ausch, Veronika, et al.
Publicado: (2020)

Essential thrombocythemia vs. pre-fibrotic/early primary myelofibrosis: discrimination by laboratory and clinical data
por: Schalling, Martin, et al.
Publicado: (2017)

Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin
por: Evstatiev, Rayko, et al.
Publicado: (2014)

Iron deficiency-induced thrombocytosis increases thrombotic tendency in rats
por: Jimenez, Kristine, et al.
Publicado: (2020)

Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia
por: Gross, Irwin, et al.
Publicado: (2016)

Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different Prognosis
por: Geissler, Klaus, et al.
Publicado: (2020)

Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
por: Gisslinger, H, et al.
Publicado: (2016)

Erratum: Clinical impact of bone marrow morphology for the diagnosis of essential thrombocythemia: comparison between the BCSH and the WHO criteria
por: Gisslinger, H, et al.
Publicado: (2017)

Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b
por: Them, Nicole CC, et al.
Publicado: (2015)

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
por: Hedenus, Michael, et al.
Publicado: (2014)

Duplex Reverse-Hybridization Assay for The Simultaneous Detection of KRAS/BRAF Mutations in FFPE-extracted Genomic DNA from Colorectal Cancer Specimens
por: Buxhofer-Ausch, Veronika, et al.
Publicado: (2013)

Size-Controlled Synthesis of Iron and Iron Oxide Nanoparticles by the Rapid Inductive Heating Method
por: Sharma, Pratikshya, et al.
Publicado: (2020)

Increased expression of HIF2α during iron deficiency–associated megakaryocytic differentiation
por: Jimenez, K., et al.
Publicado: (2015)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype
por: Heibl, Sonja, et al.
Publicado: (2020)

An Intracytoplasmic IL-10 Receptor Variant Permits Rapid Reduction in STAT3 Activation
por: Finsterbusch, Michaela, et al.
Publicado: (2011)

An interdisciplinary approach to Iron Age Mediterranean chronology through combined archaeological and (14)C-radiometric evidence from Sidon, Lebanon
por: Doumet-Serhal, Claude, et al.
Publicado: (2023)

Successful kidney transplantation in a patient with pre‐existing chronic myeloid leukemia treated with imatinib
por: Thiem, Ursula, et al.
Publicado: (2020)

TOP-PIC: a new tool to optimize pharmacotherapy and reduce polypharmacy in patients with incurable cancer
por: Strassl, Irene, et al.
Publicado: (2023)

Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside—a systematic review and meta‐analysis
por: Schaefer, Benedikt, et al.
Publicado: (2020)

Associations between tryptophan and iron metabolism observed in individuals with and without iron deficiency
por: Wenninger, Julian, et al.
Publicado: (2019)

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
por: Pleyer, Lisa, et al.
Publicado: (2016)

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
por: Viveiros, André, et al.
Publicado: (2020)

A phase III randomized, multicentre, double blind, active controlled trial to compare the efficacy and safety of two different anagrelide formulations in patients with essential thrombocythaemia – the TEAM‐ET 2·0 trial
por: Gisslinger, Heinz, et al.
Publicado: (2019)

English-German and German-English dictionary for the iron and steel industry
por: Köhler, E L, et al.
Publicado: (1955)

A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia
por: Derman, Richard, et al.
Publicado: (2017)

Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia
por: Derman, Richard, et al.
Publicado: (2018)

Objectives and Methods of Iron Chelation Therapy
por: Hershko, C., et al.
Publicado: (2003)

Current and future treatment options for polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2015)

Intravenous iron therapy among patients with heart failure and iron deficiency: An updated meta-analysis of randomized controlled trials
por: Hamed, Mohamed, et al.
Publicado: (2023)

Two common polymorphic variants of OATP4A1 as potential risk factors for colorectal cancer
por: Buxhofer-Ausch, Veronika, et al.
Publicado: (2020)

The Irony of Iron – Biogenic Iron Oxides as an Iron Source to the Ocean
por: Emerson, David
Publicado: (2016)

Gastrointestinal iron excretion and reversal of iron excess in a mouse model of inherited iron excess
por: Mercadante, Courtney J., et al.
Publicado: (2019)

Ten Things You Might Not Know about Iron Oxide Nanoparticles
por: Daldrup-Link, Heike E.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gcrcj1a9p99mtkhfdr05d4khuk